Review





Similar Products

99
Inotiv old c57bl6 male randomized mice
Old C57bl6 Male Randomized Mice, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse%3A+c57bl/C57BL%2F6+Mouse/pmc13680854-33-0-11
Average 99 stars, based on 1 article reviews
old c57bl6 male randomized mice - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC 3t3 mefs atcc crl 2752 c57bl 6 mouse b16 f10 skin melanoma
3t3 Mefs Atcc Crl 2752 C57bl 6 Mouse B16 F10 Skin Melanoma, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse%3A+c57bl/3T3+MEFs+WT/pm42906538-312-0-2
Average 99 stars, based on 1 article reviews
3t3 mefs atcc crl 2752 c57bl 6 mouse b16 f10 skin melanoma - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Inotiv wild type c57bl6 j mice
Wild Type C57bl6 J Mice, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse%3A+c57bl/C57BL%2F6+Mouse/pm42897202-320-0-6
Average 99 stars, based on 1 article reviews
wild type c57bl6 j mice - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Inotiv female c57bl 6j olahsd mice
Female C57bl 6j Olahsd Mice, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse%3A+c57bl/C57BL%2F6+Mouse/pmc13680798-46-0-7
Average 99 stars, based on 1 article reviews
female c57bl 6j olahsd mice - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Inotiv c57bl 6
C57bl 6, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse%3A+c57bl/C57BL%2F6+Mouse/10__3390_slash_futurepharmacol6040058-99-12-16
Average 99 stars, based on 1 article reviews
c57bl 6 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Inotiv c57bl 6j
C57bl 6j, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse%3A+c57bl/C57BL%2F6+Mouse/10__1016_slash_j__ero__2026__100260-62-9-10
Average 99 stars, based on 1 article reviews
c57bl 6j - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Inotiv female c57bl6 j
Female C57bl6 J, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse%3A+c57bl/C57BL%2F6+Mouse/pm42881257-353-1-13
Average 99 stars, based on 1 article reviews
female c57bl6 j - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Inotiv male c57bl 6 mice
Male C57bl 6 Mice, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse%3A+c57bl/C57BL%2F6+Mouse/pm42881217-94-2-8
Average 99 stars, based on 1 article reviews
male c57bl 6 mice - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Inotiv c57bl 6 female mice
C57bl 6 Female Mice, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse%3A+c57bl/C57BL%2F6+Mouse/pm42870294-118-0-6
Average 99 stars, based on 1 article reviews
c57bl 6 female mice - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Inotiv male c57bl 6j mice
A . Pseudotime trajectory analysis (Monocle 3) overlaid on the UMAP from , suggesting a continuous differentiation path from pre-existing naïve and/or memory populations, through the progenitor-like state, to cytotoxic effectors. B-E: Murine adoptive transfer reveals that T CM display the highest potential for expansion and differentiation into CTL TCE . B . Experimental design: T Naïve (CD44⁻ CD62L⁺), T CM (CD44⁺ CD62L⁺) and T EM (CD44⁺ CD62L⁻) CD8⁺ T cells are sorted from LckGFP hCD3ε chimeras and transferred into hCD20⁺ <t>tumor-bearing</t> <t>C57BL/6J</t> recipients (non-chimeric) one day before TCE or isotype control administration. GFP⁺ transferred cells are analyzed at day 6 post-treatment. Each dot represents one mouse; data pooled from 2 independent experiments. P values calculated by one-way ANOVA after adjustment using Tukey’s multiple comparisons test. C-D : Characterization of recovered GFP + T cells at D6 from TCE or isotype control . From top to bottom: evolution of transferred T Naïve , T CM, and T EM subsets upon TCE administration. C. Representative flow cytometric gating of recovered GFP + T cell subsets and quantification among total T cells, for each transferred subset. D. Representative gating of phenotype by CD44 and CD62L expression among recovered GFP + CD8 + T cells, and expression of cytotoxic molecules allowing the quantification of CTL TCE (GFP⁺ CD8⁺ perforin + granzyme B⁺). FACSplots from isotype-treated mice are uncolored; TCE-treated FACSplots are colored according to the sorted subset transfer (gray: T Naïve ; blue: T CM ; orange: T EM ). E . Quantification of CTL TCE among total T cells depending on subset transfer, in the spleen (left) and the blood (right). F-H: The superiority of memory subsets over naïve cells for CTL TCE generation is conserved in human co-culture experiments. F . Experimental design for human validation: T Naïve (CCR7⁺ CD45RA⁺), T CM (CCR7⁺ CD45RA⁻) and T EM (CCR7⁻) CD8⁺ T cells sorted from healthy donor PBMCs are co-cultured with hCD20⁺ B cell tumor in the presence of TCE or isotype control. Analysis is performed after 3 days of co-culture. Two different donors from 2 independent experiments are pooled (Donor 1, circles; Donor 2, diamond). P values by one-way ANOVA with adjustment by Tukey’s multiple comparison test. G . Left: Representative histograms of granzyme B expression in CD8⁺ T cells upon treatment with isotype (empty plot) or TCE (full plot), according to the type of subset in culture. Right: Quantification of the gMFI of granzyme B expression in CD8⁺ T cells upon TCE exposure, normalized to the mean gMFI in the isotype control group. H . Killing index per subset upon TCE exposure, normalized to the mean killing index in the isotype control group.
Male C57bl 6j Mice, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse%3A+c57bl/C57BL%2F6+Mouse/bio_rxiv__64898__2026__10__06__756695-253-3-9
Average 99 stars, based on 1 article reviews
male c57bl 6j mice - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


A . Pseudotime trajectory analysis (Monocle 3) overlaid on the UMAP from , suggesting a continuous differentiation path from pre-existing naïve and/or memory populations, through the progenitor-like state, to cytotoxic effectors. B-E: Murine adoptive transfer reveals that T CM display the highest potential for expansion and differentiation into CTL TCE . B . Experimental design: T Naïve (CD44⁻ CD62L⁺), T CM (CD44⁺ CD62L⁺) and T EM (CD44⁺ CD62L⁻) CD8⁺ T cells are sorted from LckGFP hCD3ε chimeras and transferred into hCD20⁺ tumor-bearing C57BL/6J recipients (non-chimeric) one day before TCE or isotype control administration. GFP⁺ transferred cells are analyzed at day 6 post-treatment. Each dot represents one mouse; data pooled from 2 independent experiments. P values calculated by one-way ANOVA after adjustment using Tukey’s multiple comparisons test. C-D : Characterization of recovered GFP + T cells at D6 from TCE or isotype control . From top to bottom: evolution of transferred T Naïve , T CM, and T EM subsets upon TCE administration. C. Representative flow cytometric gating of recovered GFP + T cell subsets and quantification among total T cells, for each transferred subset. D. Representative gating of phenotype by CD44 and CD62L expression among recovered GFP + CD8 + T cells, and expression of cytotoxic molecules allowing the quantification of CTL TCE (GFP⁺ CD8⁺ perforin + granzyme B⁺). FACSplots from isotype-treated mice are uncolored; TCE-treated FACSplots are colored according to the sorted subset transfer (gray: T Naïve ; blue: T CM ; orange: T EM ). E . Quantification of CTL TCE among total T cells depending on subset transfer, in the spleen (left) and the blood (right). F-H: The superiority of memory subsets over naïve cells for CTL TCE generation is conserved in human co-culture experiments. F . Experimental design for human validation: T Naïve (CCR7⁺ CD45RA⁺), T CM (CCR7⁺ CD45RA⁻) and T EM (CCR7⁻) CD8⁺ T cells sorted from healthy donor PBMCs are co-cultured with hCD20⁺ B cell tumor in the presence of TCE or isotype control. Analysis is performed after 3 days of co-culture. Two different donors from 2 independent experiments are pooled (Donor 1, circles; Donor 2, diamond). P values by one-way ANOVA with adjustment by Tukey’s multiple comparison test. G . Left: Representative histograms of granzyme B expression in CD8⁺ T cells upon treatment with isotype (empty plot) or TCE (full plot), according to the type of subset in culture. Right: Quantification of the gMFI of granzyme B expression in CD8⁺ T cells upon TCE exposure, normalized to the mean gMFI in the isotype control group. H . Killing index per subset upon TCE exposure, normalized to the mean killing index in the isotype control group.

Journal: bioRxiv

Article Title: T cell engagers convert acute tumor killing into endogenous vaccination

doi: 10.64898/2026.10.06.756695

Figure Lengend Snippet: A . Pseudotime trajectory analysis (Monocle 3) overlaid on the UMAP from , suggesting a continuous differentiation path from pre-existing naïve and/or memory populations, through the progenitor-like state, to cytotoxic effectors. B-E: Murine adoptive transfer reveals that T CM display the highest potential for expansion and differentiation into CTL TCE . B . Experimental design: T Naïve (CD44⁻ CD62L⁺), T CM (CD44⁺ CD62L⁺) and T EM (CD44⁺ CD62L⁻) CD8⁺ T cells are sorted from LckGFP hCD3ε chimeras and transferred into hCD20⁺ tumor-bearing C57BL/6J recipients (non-chimeric) one day before TCE or isotype control administration. GFP⁺ transferred cells are analyzed at day 6 post-treatment. Each dot represents one mouse; data pooled from 2 independent experiments. P values calculated by one-way ANOVA after adjustment using Tukey’s multiple comparisons test. C-D : Characterization of recovered GFP + T cells at D6 from TCE or isotype control . From top to bottom: evolution of transferred T Naïve , T CM, and T EM subsets upon TCE administration. C. Representative flow cytometric gating of recovered GFP + T cell subsets and quantification among total T cells, for each transferred subset. D. Representative gating of phenotype by CD44 and CD62L expression among recovered GFP + CD8 + T cells, and expression of cytotoxic molecules allowing the quantification of CTL TCE (GFP⁺ CD8⁺ perforin + granzyme B⁺). FACSplots from isotype-treated mice are uncolored; TCE-treated FACSplots are colored according to the sorted subset transfer (gray: T Naïve ; blue: T CM ; orange: T EM ). E . Quantification of CTL TCE among total T cells depending on subset transfer, in the spleen (left) and the blood (right). F-H: The superiority of memory subsets over naïve cells for CTL TCE generation is conserved in human co-culture experiments. F . Experimental design for human validation: T Naïve (CCR7⁺ CD45RA⁺), T CM (CCR7⁺ CD45RA⁻) and T EM (CCR7⁻) CD8⁺ T cells sorted from healthy donor PBMCs are co-cultured with hCD20⁺ B cell tumor in the presence of TCE or isotype control. Analysis is performed after 3 days of co-culture. Two different donors from 2 independent experiments are pooled (Donor 1, circles; Donor 2, diamond). P values by one-way ANOVA with adjustment by Tukey’s multiple comparison test. G . Left: Representative histograms of granzyme B expression in CD8⁺ T cells upon treatment with isotype (empty plot) or TCE (full plot), according to the type of subset in culture. Right: Quantification of the gMFI of granzyme B expression in CD8⁺ T cells upon TCE exposure, normalized to the mean gMFI in the isotype control group. H . Killing index per subset upon TCE exposure, normalized to the mean killing index in the isotype control group.

Article Snippet: Six to eight-week-old male C57BL/6J mice were obtained from Envigo.

Techniques: Analysis, Adoptive Transfer Assay, Control, Expressing, Co-culture Assay, Biomarker Discovery, Cell Culture, Comparison, Cell Differentiation, Transmission Electron Microscopy, Co-Culture